Position in GILD
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$22,362
-$2,305 QoQ
Shares Held
177
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#2,131
of 2,265 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 8%
Shared 0%
None 92%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Aspect Partners, LLC holds $583,966 across 9 Drug Manufacturers - General names. GILD ranks #6 (3.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
570 | $144,762 | |
| 2 | LLY |
ELI LILLY & Co
|
101 | $121,142 | |
| 3 | AMGN |
Amgen Inc
|
333 | $120,585 | |
| 4 | MRK |
Merck & Co., Inc.
|
703 | $90,335 | |
| 5 | ABBV |
AbbVie Inc.
|
249 | $62,658 | |
| 6 | GILD |
Gilead Sciences, Inc.
This page
|
177 | $22,362 | |
| 7 | PFE |
Pfizer Inc
|
577 | $13,894 | |
| 8 | NVO |
Novo Nordisk A S
|
166 | $7,958 |
All Filings in GILD
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $22,362 | 177 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $24,667 | 177 | Shares | Sole | 2026-04-02 | |
| 2025-12-31 | $21,724 | 177 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $17,982 | 162 | Shares | Other | 2025-11-06 | |
| 2025-06-30 | $35,699 | 322 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $18,600 | 166 | Shares | Other | 2025-04-24 | |
| 2024-12-31 | $14,686 | 159 | Shares | Other | 2025-02-03 | |
| 2024-09-30 | $12,240 | 146 | Shares | Other | 2024-10-15 | |
| 2024-06-30 | $10,017 | 146 | Shares | Other | 2024-07-15 | |
| 2024-03-31 | $10,694 | 146 | Shares | Other | 2024-05-17 | |
| 2023-12-31 | $12,637 | 156 | Shares | Other | 2024-02-16 | |
| No filing history on record for this holder in this stock. | ||||||